Stay informed with the latest litigation news. Explore now

IP Verse

Amylin Pharmaceuticals competitive analysis

Latest publications and patents of Amylin Pharmaceuticals New

Explore the latest publications and patents granted to Amylin Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Amylin Pharmaceuticals

EP2341905
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous CarriersPatent Maintained As Amended
EP2347762
May 8, 2019Exendin For Treating Diabetes And Reducing Body WeightRevoked

Latest patents of Amylin Pharmaceuticals opposed by its competitors

Explore Amylin Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2341905
Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers1
EP2347762
May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight2

Latest PTAB cases involving Amylin Pharmaceuticals New

Discover the latest PTAB cases involving Amylin Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Amylin Pharmaceuticals

IPR2016-00355Dec 16, 2015SANOFI AVENTISAMYLIN PHARMACEUTICALSTerminated-Settled
IPR2016-00354Dec 16, 2015SANOFI AVENTISAMYLIN PHARMACEUTICALSTerminated-Settled
IPR2016-00353Dec 16, 2015SANOFI AVENTISAMYLIN PHARMACEUTICALSTerminated-Settled
IPR2016-00348Dec 16, 2015SANOFI AVENTISAMYLIN PHARMACEUTICALSInstitution Denied

Top competitors of Amylin Pharmaceuticals

Top competitors of Amylin Pharmaceuticals based on patent oppositions.